ID

27395

Beskrivning

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT00548093

Länk

https://clinicaltrials.gov/show/NCT00548093

Nyckelord

  1. 2017-11-13 2017-11-13 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

13 november 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
advanced non-small cell lung cancer (nsclc)
Beskrivning

Non-Small Cell Lung Carcinoma Advanced

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
Beskrivning

Chemotherapy Regimen Quantity failed | erlotinib

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C1135135
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
Beskrivning

Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0085533
UMLS CUI [3]
C0009429
measurable disease .
Beskrivning

Measurable Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status 0-2
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
tissue available for kras/ egfr testing
Beskrivning

Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C3537133
UMLS CUI [2,1]
C1292533
UMLS CUI [2,2]
C0470187
UMLS CUI [2,3]
C3497772
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
Beskrivning

Creatinine clearance measurement | Creatinine measurement, serum

Datatyp

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C0201976
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
chemotherapy
Beskrivning

Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
radiotherapy
Beskrivning

Therapeutic radiology procedure

Datatyp

boolean

Alias
UMLS CUI [1]
C1522449
biological or investigational agents within 4 weeks of baseline disease assessment.
Beskrivning

Biological Factors | Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0005515
UMLS CUI [2]
C0013230
patients who lack of tolerance of erlotinib therapy.
Beskrivning

Intolerance to erlotinib

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1135135

Similar models

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced
Item
advanced non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity failed | erlotinib
Item
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1135135 (UMLS CUI [2])
Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy
Item
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
Measurable Disease
Item
measurable disease .
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)
Item
tissue available for kras/ egfr testing
boolean
C1292533 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3537133 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
C3497772 (UMLS CUI [2,3])
Creatinine clearance measurement | Creatinine measurement, serum
Item
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
boolean
C0373595 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
Biological Factors | Investigational New Drugs
Item
biological or investigational agents within 4 weeks of baseline disease assessment.
boolean
C0005515 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Intolerance to erlotinib
Item
patients who lack of tolerance of erlotinib therapy.
boolean
C1744706 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial